Max Nisen is a Bloomberg Gadfly columnist covering biotech, pharma and health care. He previously wrote about management and corporate strategy for Quartz and Business Insider.

Good morning! This is Fly Charts, the daily charts-only newsletter from Gadfly; sign up here. From Qatari fallout to endangered stock bears, here are four charts that tell you what you need to know in business today.

Lucre List
Qatar's geopolitical issues serve as a reminder that cash from abroad may not always be totally reliable.
Source: Sovereign Wealth Fund Institute
Note: Data as of June 2016.
A New Way into Stocks
Is there still cash on the sidelines in the U.S.? It depends on where you look.
Source: Investment Company Institute
Note: 2017 YTD is through April
Up, Up and Away
Coherent's acquisition of Rofin-Sinar was a bear to get done, but it's more than paying off.
Source: Bloomberg
Changing of the Guard
Merck's Keytruda is gunning for a lead in the immune-oncology market, and it may get an unexpected boost at Eli Lilly’s expense.
Source: Bloomberg

And don't miss Nisha Gopalan on China's dirty dinosaur: "The combination with China Guodian Corp. wouldn't achieve either of the goals of President Xi Jinping's power-industry restructuring: overhauling bloated state companies and cutting reliance on coal. Instead, it would create another too-big-to-fail near-monopoly akin to the December 2015 formation of the Cosco-China Shipping Group." 

Correction: The "Printing Money" chart in Monday's edition said "billion" instead of "trillion." 

This column does not necessarily reflect the opinion of Bloomberg LP and its owners.

To contact the author of this story:
Max Nisen in New York at

To contact the editor responsible for this story:
Mark Gongloff at